Google's AI Mode, FDA's Elsa, and AI in Healthcare Policy
In this episode, Bob opens with an introduction and overview of the topics to be discussed. The focus shifts to Google's "AI Mode" and the competitive landscape of developing "everything apps." He then examines the challenges and recent issues faced in AI advancements. The conversation highlights the FDA's new generative AI tool, Elsa, and its potential impact on healthcare. Bob also discusses President Trump's 2026 budget proposal and its implications for AI in the healthcare sector. The episode concludes with a summary and sign-off.
Key Points
- Google has launched "AI Mode," an overhaul of its search engine that uses a chatbot to handle queries and tasks, aiming to make traditional search bars obsolete.
- Major tech companies like OpenAI, Meta, Microsoft, and Apple are developing "everything apps" that integrate deeply into users' personal lives, raising both convenience and data privacy concerns.
- Despite budget cuts, the FDA has launched a generative AI tool named Elsa ahead of schedule, designed to assist with clinical protocol reviews and scientific evaluations, marking a significant step in the agency's AI journey.
Chapters
| 0:00 | |
| 0:24 | |
| 1:56 | |
| 2:23 | |
| 4:12 | |
| 4:56 |
Transcript
Loading transcript...
- / -